Additionally, CRNDE promotes metabolic changes in CRC mainly by upregulating the genes responsible for glucose-6-phosphate anabolic reactions (GYS1, G6PC3, ISYNA1 and G6PD). The gene discussed is G6PC3; the disease is colorectal carcinoma.